Ethics of treatment interruption trials in HIV cure research: addressing the conundrum of risk/benefit assessment

Though antiretroviral therapy is the standard of care for people living with HIV, its treatment limitations, burdens, stigma and costs lead to continued interest in HIV cure research. Early-phase cure trials, particularly those that include analytic treatment interruption (ATI), involve uncertain an...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Med Ethics
Auteurs principaux: Henderson, Gail E, Peay, Holly L, Kroon, Eugene, Cadigan, Rosemary Jean, Meagher, Karen, Jupimai, Thidarat, Gilbertson, Adam, Fisher, Jill, Ormsby, Nuchanart Q, Chomchey, Nitiya, Phanuphak, Nittaya, Ananworanich, Jintanat, Rennie, Stuart
Format: Artigo
Langue:Inglês
Publié: BMJ Publishing Group 2018
Sujets:
Research Ethics
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5869463/
https://ncbi.nlm.nih.gov/pubmed/29127137
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/medethics-2017-104433
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires